These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8610532)

  • 1. Preclinical pharmacokinetics and general toxicology of iodixanol.
    Heglund IF; Michelet AA; Blazak WF; Furuhama K; Holtz E
    Acta Radiol Suppl; 1995; 399():69-82. PubMed ID: 8610532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of iodixanol in experimental animals.
    Walday P; Heglund IF; Golman K; Cornacoff J; Holtz E
    Acta Radiol Suppl; 1995; 399():204-12. PubMed ID: 8610517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
    Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H
    Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reproductive toxicity of iodixanol, a new non-ionic, iso-tonic contrast medium in rats and rabbits].
    Fujikawa K; Sakaguchi Y; Harada S; Holtz E; Smith JA; Svendsen O
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():107-15. PubMed ID: 7490782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigenicity study of iodixanol, a new non-ionic contrast medium].
    Hattori H; Yamaguchi F; Ohno H; Nomura M
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():117-23. PubMed ID: 7490783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human pharmacokinetics of iodixanol.
    Svaland MG; Haider T; Langseth-Manrique K; Andrew E; Hals PA
    Invest Radiol; 1992 Feb; 27(2):130-3. PubMed ID: 1601604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical safety assessment of Vasovist (Gadofosveset trisodium), a new magnetic resonance imaging contrast agent for angiography.
    Steger-Hartmann T; Graham PB; Müller S; Schweinfurth H
    Invest Radiol; 2006 May; 41(5):449-59. PubMed ID: 16625108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodixanol 320 results in better renal tolerance and radiodensity than do gadolinium-based contrast media: arteriography in ischemic porcine kidneys.
    Elmståhl B; Nyman U; Leander P; Golman K; Chai CM; Grant D; Doughty R; Pehrson R; Björk J; Almén T
    Radiology; 2008 Apr; 247(1):88-97. PubMed ID: 18292474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption and excretion of iodixanol after intragastric administration to rats.
    Dunkel JA; Helund IF; Jacobsen PB; Grant D; Walday P; Refsum H
    Acta Radiol Suppl; 1995; 399():253-7. PubMed ID: 8610524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous single dose toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, in mice, rats and monkeys].
    Genda Y; Yamamura H; Takahashi Y; Ishijima N; Furuhama K; Kakihata K; Ohno H; Nomura M
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():47-66. PubMed ID: 7490789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to rats by repeated intravenous administration for 4 weeks with a 4-week recovery period].
    Ohno H; Crome SJ; Furuhama K; Nomura M; Onodera T
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():67-85. PubMed ID: 7490790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
    Morisetti A; Tirone P; Luzzani F; de Haën C
    Eur J Radiol; 1994 May; 18 Suppl 1():S21-31. PubMed ID: 8020516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutagenicity studies of iodixanol, a new non-ionic isotonic contrast medium].
    Igarashi M; Nakayama S; Jones E; Shimada H
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():125-31. PubMed ID: 7490784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal contrast agents for vascular imaging on computed tomography: iodixanol versus iohexol.
    Pannu HK; Thompson RE; Phelps J; Magee CA; Fishman EK
    Acad Radiol; 2005 May; 12(5):576-84. PubMed ID: 15866130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicity of iodixanol, a new nonionic iso-osmolar contrast medium, to cynomolgus monkeys by repeated intravenous administration for 4 weeks with a 4-week recovery period].
    Ohno H; Crome SJ; Genda Y; Furuhama K; Nomura M; Onodera T
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():87-105. PubMed ID: 7490791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotransformation of nonionic X-Ray contrast agents In vivo and In vitro.
    Jacobsen PB; Larsen A; Konarboland R; Skotland T
    Drug Metab Dispos; 1999 Oct; 27(10):1205-13. PubMed ID: 10497149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of non-ionic monomeric and dimeric iodinated contrast media on renal and systemic haemodynamics in rats.
    Idée JM; Lancelot E; Berthommier C; Couturier-Goulas V; Vazin V; Corot C
    Fundam Clin Pharmacol; 2000; 14(1):11-8. PubMed ID: 10681069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GE-145, a new low-osmolar dimeric radiographic contrast medium.
    Wistrand LG; Rogstad A; Hagelin G; Roed L; Oulie I; Gram A; Evans P; Rasmussen H; Grant D; Iveson P; Newton B; Thaning M
    Acta Radiol; 2010 Nov; 51(9):1014-20. PubMed ID: 20849319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of iodinated contrast agent properties on renal kinetics and oxygenation.
    Lenhard DC; Frisk AL; Lengsfeld P; Pietsch H; Jost G
    Invest Radiol; 2013 Apr; 48(4):175-82. PubMed ID: 23262792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [General pharmacological study of iodixanol, a new non-ionic isotonic contrast medium].
    Takasuna K; Kasai Y; Kitano Y; Mori K; Kobayashi R; Makino M; Hagiwara T; Hirohashi M; Nomura M; Algate DR
    J Toxicol Sci; 1995 Oct; 20 Suppl 1():133-51. PubMed ID: 7490785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.